<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002156'>Homocystinuria</z:hpo> is an inborn error of methionine metabolism that results in raised serum levels of the highly reactive <z:chebi fb="0" ids="29256">thiol</z:chebi>-containing amino acid <z:chebi fb="0" ids="17230">homocysteine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Homocystinurics often exhibit <z:hpo ids='HP_0000118'>phenotypic abnormalities</z:hpo> that are similar to those found in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>), a <z:e sem="disease" ids="C0410787" disease_type="Disease or Syndrome" abbrv="">heritable connective tissue disorder</z:e> that is caused by reduced levels of, or defects in, the cysteine-rich extracellular matrix (ECM) protein fibrillin-1 </plain></SENT>
<SENT sid="2" pm="."><plain>The phenotypic similarities between <z:hpo ids='HP_0002156'>homocystinuria</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> suggest that elevated <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels may result in an altered function of fibrillin-1 </plain></SENT>
<SENT sid="3" pm="."><plain>We have used recombinant calcium binding epidermal growth factor-like (cbEGF) domain fragments from fibrillin-1, and an unrelated protein Notch1, to analyse the effects of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> on the native disulphide (<z:chebi fb="0" ids="17376">cystine</z:chebi>) bonds of these domains </plain></SENT>
<SENT sid="4" pm="."><plain>We show using analytical reverse phase, high performance liquid chromatography (HPLC), electrospray ionisation mass spectrometry (ESI-MS) and limited proteolysis that <z:chebi fb="0" ids="17230">homocysteine</z:chebi> attacks intramolecular disulphide bonds causing reduction of <z:chebi fb="0" ids="17376">cystine</z:chebi> and domain misfolding, and that the effects of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> are dependent on its concentration </plain></SENT>
<SENT sid="5" pm="."><plain>We also identify the importance of calcium binding to cbEGF domains for their stabilisation and protection against <z:chebi fb="0" ids="17230">homocysteine</z:chebi> attack </plain></SENT>
<SENT sid="6" pm="."><plain>Collectively, these data suggest that reduction of intramolecular cbEGF domain disulphide bonds by <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and the resulting disruption of this domain fold may contribute to the change in connective tissue function seen in <z:hpo ids='HP_0002156'>homocystinuria</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, since we show that the effects of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> are not unique to fibrillin-1, other cbEGF-containing proteins may be implicated in the pathogenic mechanisms underlying <z:hpo ids='HP_0002156'>homocystinuria</z:hpo> </plain></SENT>
</text></document>